Adjusting the Lens: Real World Outcomes in Nephrotic Syndrome
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Li X, Liu Z, Wang L, Wang R, Ding G, Shi W
. Tacrolimus Monotherapy after Intravenous Methylprednisolone in Adults with Minimal Change Nephrotic Syndrome. J Am Soc Nephrol. 2016; 28(4):1286-1295.
PMC: 5373446.
DOI: 10.1681/ASN.2016030342.
View
2.
Medjeral-Thomas N, Lawrence C, Condon M, Sood B, Warwicker P, Brown H
. Randomized, Controlled Trial of Tacrolimus and Prednisolone Monotherapy for Adults with Minimal Change Disease: A Multicenter, Randomized, Controlled Trial. Clin J Am Soc Nephrol. 2020; 15(2):209-218.
PMC: 7015084.
DOI: 10.2215/CJN.06180519.
View
3.
Coggins C
. Adult minimal change nephropathy: experience of the collaborative study of glomerular disease. Trans Am Clin Climatol Assoc. 1985; 97:18-26.
PMC: 2279687.
View
4.
Maas R, Deegens J, Beukhof J, Reichert L, Ten Dam M, Beutler J
. The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series. Am J Kidney Dis. 2017; 69(5):637-646.
DOI: 10.1053/j.ajkd.2016.10.032.
View
5.
Black D, Rose G, BREWER D
. Controlled trial of prednisone in adult patients with the nephrotic syndrome. Br Med J. 1970; 3(5720):421-6.
PMC: 1701394.
DOI: 10.1136/bmj.3.5720.421.
View